ACE and chronic obstructive pulmonary disease: Sympathetic activation is known to increase arterial stiffness and raises an interesting consideration that therapeutic modulation, such as with ACE inhibitors, that are CV protective, decrease sympathetic nervous system (SNS) activation and confer renal benefit might have a role in COPD.